These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 3774074)

  • 1. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
    Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
    Li JH; Wu ZG; Xu JQ; Zhou Y
    Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin-like immunoreactive substance in renal transplant patients.
    Schrader BJ; Maddux MS; Veremis SA; Mozes MF; Maturen A; Bauman JL
    J Clin Pharmacol; 1991 Dec; 31(12):1126-31. PubMed ID: 1662232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of free digoxin and total digoxin: extent of interference from digoxin-like immunoreactive substances (DLIS) in a fluorescence polarization assay.
    Dasgupta A; Nakamura A; Doria L; Dennen D
    Clin Chem; 1989 Feb; 35(2):323-4. PubMed ID: 2914387
    [No Abstract]   [Full Text] [Related]  

  • 9. Inaccuracies in digoxin measurement.
    Cook JD; Koch TR; Cook MS; Knoblock EC
    Clin Biochem; 1988 Dec; 21(6):353-7. PubMed ID: 3233747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin-like substance in amniotic fluid--fact or artifact?
    Greenway DC; Nanji AA
    Gynecol Obstet Invest; 1986; 22(2):108-9. PubMed ID: 3770531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.
    Howarth DM; Sampson DC; Hawker FH; Young A
    Anaesth Intensive Care; 1990 Feb; 18(1):45-52. PubMed ID: 2159733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tentative identification of a digoxin-like immunoreactive substance.
    Toseland PA; Oldfield PR; Murphy GM; Lawson AM
    Ther Drug Monit; 1988; 10(2):168-71. PubMed ID: 3381233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin radioimmunoassay that does not detect digoxin-like substance in serum of newborns, infants, or patients with renal failure.
    Witherspoon L; Shuler S; Neely H; Sonnemaker R; Alyea K; Gilbert S
    Clin Chem; 1987 Mar; 33(3):420. PubMed ID: 3815819
    [No Abstract]   [Full Text] [Related]  

  • 14. Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS.
    Gervais A; Nanji AA; Greenway DC; McLean W
    Drug Intell Clin Pharm; 1987 May; 21(5):450-2. PubMed ID: 3582173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-multiplied immunoassay (EMIT 2000) digoxin assay compared with fluorescence polarization immunoassay and amerlex 125I-radioimmunoassay at two Australian centers.
    Saccoia NC; Hackett LP; Morris RG; Ilett KF
    Ther Drug Monit; 1996 Dec; 18(6):672-7. PubMed ID: 8946664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
    Marzullo C; Bourderont D; Dorr R
    Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
    Lackner TE; Lau BW; Parvin C; Valdes R
    Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falsely elevated serum digoxin levels secondary to endogenous digoxin-like immunoreactive substances.
    Koobatian TJ; Roberts JR
    Acad Emerg Med; 1995 Apr; 2(4):322-6. PubMed ID: 11727693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
    Li J; Wu Z; Xu J; Zhou Y; Chu X
    Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.